> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Indivior's $488 Million Convertible Debt Turns Current Ahead Of $1 Billion Special Dividend
- URL: https://www.bullished.co/indiviors-488-million-convertible-debt-turns-current-ahead-of-1-billion-special-dividend-a7410f90/
- Published: 2026-10-29T12:36:20.000Z
- Updated: 2026-10-29T12:36:20.000Z
- Description: A temporary conversion right tied to the dividend flipped the notes to a current liability and left a $501 million working capital deficit.
- Author: Matteo Parrino
- Tags: SEC Filings, SUPN, Industry: Healthcare

[Indivior](https://www.bullished.co/tag/indv/), which sells prescription medicines for opioid use disorder, now carries [$488 million of convertible notes as a current liability](https://www.sec.gov/Archives/edgar/data/0001625297/000162828026068013/indv-20260930.htm?ref=bullished.co), leaving its current liabilities $501 million above its current assets, according to its 10-Q filed Thursday. The trigger is a $1,000 million special dividend tied to the merger with Supernus, which the company expects to close on or about November 2.

## Why the notes turned current

The company declared the special dividend on September 16\. Under the terms of its 0.625% convertible notes due 2031, that gave holders a temporary right to convert, which forced the outstanding principal into current liabilities at September 30\. The right expires after the October 30 record date, and the company expects the notes to return to noncurrent by December 31, 2026.

The [prior quarter's 10-Q](https://www.sec.gov/Archives/edgar/data/0001625297/000162828026051895/indv-20260630.htm?ref=bullished.co) carried the notes as long-term debt, with a carrying value of $487 million. At September 30 the carrying value was $488 million, and total liabilities exceeded total assets by $60 million. The notes' estimated fair value was about $526 million.

Indivior also said it expects to keep running with negative working capital because rebate payments come due before it collects receivables.

## A dividend larger than its cash

The dividend works out to $8.13 per share and is payable after the merger takes effect to holders of record on October 30\. Indivior has a commitment from Citibank for a $650 million senior secured term loan, which together with the combined company's cash is expected to fund the payout. The company ended September with $332 million of cash and investments.

If debt financing is unavailable, the dividend would instead be split into a $500 million cash payment at closing and a $529 million dividend payment right payable before the first anniversary of closing.

## A record quarter beneath the balance sheet

Indivior makes Sublocade, a monthly buprenorphine injection, and Suboxone Film. Third-quarter net revenue was [$356 million, up 13%](https://www.sec.gov/Archives/edgar/data/0001625297/000119312526436953/d169609dex991.htm?ref=bullished.co), with Sublocade at $267 million, up 22%. Net income was $137 million.

The filing also discloses a October 19 deal to sell its French and German SUBUTEX tablet operations, a Suboxone-line product, for $95 million. It also booked a $7 million charge for ending a tablet manufacturing agreement. No shares were repurchased in the quarter, and $100 million remains under the $400 million buyback program.

## Closing and the new ticker

Stockholders of both companies approved the merger on October 15\. The combined company will be named Supernus, Inc. and is slated to trade as SUPN on Nasdaq from November 3\. Indivior holders are expected to own about 56.5% of it on a fully diluted basis.

The conversion window shuts after October 30, and the merger is slated to close on or about November 2.

### Sources

- [10-Q Filing — Indivior (INDV)](https://www.sec.gov/Archives/edgar/data/0001625297/000162828026068013/indv-20260930.htm?ref=bullished.co) — SEC EDGAR
- [10-Q Filing — Indivior (INDV), Q2 FY2026 filed 2026-08-03 (comparison basis)](https://www.sec.gov/Archives/edgar/data/0001625297/000162828026051895/indv-20260630.htm?ref=bullished.co) — SEC EDGAR
- [Earnings release (8-K Item 2.02, d169609dex991.htm) — Indivior, filed 2026-10-29](https://www.sec.gov/Archives/edgar/data/0001625297/000119312526436953/d169609dex991.htm?ref=bullished.co) — SEC EDGAR
- [Indivior Non-GAAP EPS of $1.32 beats by $0.19, revenue of $356M beats by $26.65M (INDV:NASDAQ)](https://seekingalpha.com/news/4660071-indivior-non-gaap-eps-of-1%5F32-beats-by-0%5F19-revenue-of-356m-beats-by-26%5F65m?ref=bullished.co) — seekingalpha.com
- [Sandoval v. Indivior Inc., et al.](https://www.law360.com/cases/6adb7c92e8e3de18e00643f7?ref=bullished.co) — law360.com
- [Hanson v. Indivior Inc., et al.](https://www.law360.com/cases/6ac7c48431cd61c0d289728d?ref=bullished.co) — law360.com
- [Nevius v. Indivior Inc., et al.](https://www.law360.com/cases/6adbd183f23fb4f02d40cce0?ref=bullished.co) — law360.com
- [Faye v. Indivior, Inc. et al.](https://www.law360.com/cases/6ab3fe0c7d97192a3261c832?ref=bullished.co) — law360.com

### More on Indivior

- [Indivior's Quarterly Profit Hits Record $137 Million Days Before Supernus Merger Is Set To Close](https://www.bullished.co/indiviors-quarterly-profit-hits-record-137-million-days-before-supernus-merger-is-set-to-e4e14516/)
- [Indivior And Supernus Add Cantor Valuation Detail To Merger Proxy, Denying Any Disclosure Was Required](https://www.bullished.co/indivior-and-supernus-add-cantor-valuation-detail-to-merger-proxy-denying-any-disclosure-6e50827c/)

[All Indivior (INDV) coverage →](https://www.bullished.co/tag/indv/)